Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-14

Clinical Trial Update: PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial evaluates PRG in combination with autologous bone marrow-derived mesenchymal stem cells for diabetic foot ulcers. The current trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous bone marrow mesenchymal stem cells (mesenchymal stem cells)
  • PRG

Snippet

Sponsor: Third Military Medical University | Conditions: Diabetic Foot Ulcer | EARLY_Phase 1 | Status: UNKNOWN